![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ZBTB41 |
Gene summary for ZBTB41 |
![]() |
Gene information | Species | Human | Gene symbol | ZBTB41 | Gene ID | 360023 |
Gene name | zinc finger and BTB domain containing 41 | |
Gene Alias | FRBZ1 | |
Cytomap | 1q31.3 | |
Gene Type | protein-coding | GO ID | GO:0006139 | UniProtAcc | Q5SVQ8 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
360023 | ZBTB41 | HCC1_Meng | Human | Liver | HCC | 3.08e-40 | 8.88e-02 | 0.0246 |
360023 | ZBTB41 | HCC2_Meng | Human | Liver | HCC | 9.15e-19 | 1.59e-01 | 0.0107 |
360023 | ZBTB41 | HCC1 | Human | Liver | HCC | 9.07e-05 | 2.86e+00 | 0.5336 |
360023 | ZBTB41 | HCC2 | Human | Liver | HCC | 3.78e-11 | 2.86e+00 | 0.5341 |
360023 | ZBTB41 | S016 | Human | Liver | HCC | 5.37e-03 | 1.69e-01 | 0.2243 |
360023 | ZBTB41 | S027 | Human | Liver | HCC | 5.93e-04 | 4.50e-01 | 0.2446 |
360023 | ZBTB41 | S028 | Human | Liver | HCC | 2.21e-16 | 6.04e-01 | 0.2503 |
360023 | ZBTB41 | S029 | Human | Liver | HCC | 1.13e-10 | 5.71e-01 | 0.2581 |
360023 | ZBTB41 | male-WTA | Human | Thyroid | PTC | 6.60e-10 | 1.08e-01 | 0.1037 |
360023 | ZBTB41 | PTC01 | Human | Thyroid | PTC | 3.39e-04 | 1.15e-02 | 0.1899 |
360023 | ZBTB41 | PTC04 | Human | Thyroid | PTC | 4.46e-08 | 1.18e-01 | 0.1927 |
360023 | ZBTB41 | PTC05 | Human | Thyroid | PTC | 1.56e-04 | 3.07e-01 | 0.2065 |
360023 | ZBTB41 | PTC06 | Human | Thyroid | PTC | 6.50e-20 | 3.88e-01 | 0.2057 |
360023 | ZBTB41 | PTC07 | Human | Thyroid | PTC | 3.27e-26 | 2.43e-01 | 0.2044 |
360023 | ZBTB41 | ATC12 | Human | Thyroid | ATC | 5.05e-09 | 1.15e-01 | 0.34 |
360023 | ZBTB41 | ATC13 | Human | Thyroid | ATC | 7.67e-27 | 6.42e-01 | 0.34 |
360023 | ZBTB41 | ATC2 | Human | Thyroid | ATC | 1.88e-09 | 6.30e-01 | 0.34 |
360023 | ZBTB41 | ATC4 | Human | Thyroid | ATC | 2.68e-07 | 1.72e-01 | 0.34 |
360023 | ZBTB41 | ATC5 | Human | Thyroid | ATC | 4.30e-36 | 6.77e-01 | 0.34 |
Page: 1 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
ZBTB41 | SNV | Missense_Mutation | c.529N>A | p.Glu177Lys | p.E177K | Q5SVQ8 | protein_coding | tolerated_low_confidence(0.18) | possibly_damaging(0.812) | TCGA-BS-A0UF-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
ZBTB41 | SNV | Missense_Mutation | c.2516N>G | p.Leu839Arg | p.L839R | Q5SVQ8 | protein_coding | deleterious_low_confidence(0.01) | possibly_damaging(0.798) | TCGA-BS-A0UJ-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
ZBTB41 | SNV | Missense_Mutation | c.2252N>A | p.Ser751Tyr | p.S751Y | Q5SVQ8 | protein_coding | tolerated(0.18) | benign(0.037) | TCGA-BS-A0UV-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD | |
ZBTB41 | SNV | Missense_Mutation | c.316N>A | p.Val106Ile | p.V106I | Q5SVQ8 | protein_coding | deleterious_low_confidence(0.02) | possibly_damaging(0.495) | TCGA-BS-A0UV-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD | |
ZBTB41 | SNV | Missense_Mutation | novel | c.464N>G | p.Ile155Arg | p.I155R | Q5SVQ8 | protein_coding | deleterious_low_confidence(0) | possibly_damaging(0.801) | TCGA-D1-A16X-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
ZBTB41 | SNV | Missense_Mutation | rs577928695 | c.441N>T | p.Glu147Asp | p.E147D | Q5SVQ8 | protein_coding | deleterious_low_confidence(0.01) | possibly_damaging(0.811) | TCGA-D1-A175-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | paclitaxel | SD |
ZBTB41 | SNV | Missense_Mutation | novel | c.2692G>T | p.Gly898Cys | p.G898C | Q5SVQ8 | protein_coding | deleterious_low_confidence(0.02) | benign(0.054) | TCGA-DF-A2KN-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | Unknown | I/II | Unknown | Unknown | SD |
ZBTB41 | SNV | Missense_Mutation | rs369802586 | c.2482N>G | p.Thr828Ala | p.T828A | Q5SVQ8 | protein_coding | tolerated(0.42) | benign(0.014) | TCGA-DI-A1BU-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | paclitaxel | SD |
ZBTB41 | SNV | Missense_Mutation | novel | c.694N>C | p.Ser232Pro | p.S232P | Q5SVQ8 | protein_coding | tolerated_low_confidence(0.05) | benign(0) | TCGA-DI-A1BU-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | paclitaxel | SD |
ZBTB41 | SNV | Missense_Mutation | novel | c.2389N>C | p.Thr797Pro | p.T797P | Q5SVQ8 | protein_coding | tolerated(0.13) | benign(0) | TCGA-EO-A22R-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |